PAT and Data Analytics: Missing Pieces of the Upstream Process Intensification Puzzle
PAT, process modeling, and process control are pivotal to support the shift toward process intensification, but are downstream risks associated with higher upstream titers holding the industry back?
This webinar explores different PAT and data analytics that can be used stand-alone or in combination to develop intensified processes. Attendees will be able to assess how these processes perform in real-time, and if all is functioning as intended.
- Learn how PAT and data analytics can help address downstream risks of upstream process intensification
- Discover Sartorius PAT and data analytics tools that span the product lifecycle
- Know how companies can position themselves to ensure PI success
Meet Our Experts
Technology Consultant PAT | BIA Separations
Henry Weichert is a Technology Consultant PAT, based in Göttingen, Germany. Henry originally joined Sartorius in 2010 as a Product Manager in Integrated Solutions where he was responsible for cross-functional components, with significant focus on single-use sensors. In 2011 he transitioned into the newly created group of PAT & Automation, managing sensor and analytical systems. In 2018 he moved to the global role of Technology Consultant with the responsibility of strengthen the Sartorius PAT portfolio.
Henry has more than 25 years of progressive experience in cell culture, fermentation, cell line development and corresponding analytics. Prior to joining Sartorius, he was the founder and owner of a fermentation and cell line development company. Henry holds a PhD in Immunology from the University Leipzig.
Life Science Market Manager | BIA Separations
Tiffany McLeod is the Life Science Market Manager within the Sartorius Data Analytics team. She has been with Sartorius since 2017, analyzing trends and demands for data driven solutions within the pharma and biopharmaceutical industries. She holds a degree in Bioengineering and Bioinformatics from the University of California, San Diego. Tiffany is passionate about Biopharma 4.0 and helping businesses pursue digital transformations.